Trial
NCT02531295
Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
University of Utah; amfAR, The Foundation for AIDS Research
Condition
HIV
Intervention
Euphorbia kansui extract powder prepared as tea
Why stopped
Pause on clinical trial enrollment due to grant funding cuts after COVID-19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-19